HomeCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Previous close
$177.85
Day range
$160.01 - $180.19
Year range
$91.86 - $230.02
Market cap
8.05B USD
Avg Volume
1.02M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.03B | 0.59% |
Operating expense | 211.51M | 8.67% |
Net income | 52.33M | -44.38% |
Net profit margin | 5.07 | -44.71% |
Earnings per share | 3.12 | 11.43% |
EBITDA | 327.04M | 26.18% |
Effective tax rate | 26.22% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.82M | 2.01% |
Total assets | 7.56B | -4.88% |
Total liabilities | 4.16B | -0.34% |
Total equity | 3.40B | — |
Shares outstanding | 49.21M | — |
Price to book | 2.61 | — |
Return on assets | 5.68% | — |
Return on capital | 6.93% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 52.33M | -44.38% |
Cash from operations | 204.60M | 5.72% |
Cash from investing | -37.34M | 39.65% |
Cash from financing | -226.92M | 20.62% |
Net change in cash | -46.99M | 70.17% |
Free cash flow | 228.38M | 54.82% |
About
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Founded
1947
Headquarters
Website
Employees
19,400